A multilocus genotyping assay for candidate markers of cardiovascular disease risk

Genome Research

Volumn 9, Issue 10, 1999, Pages 936-949

  Cheng, Suzanne ^a,f   Grow, Michael A ^a   Pallaud, Céline ^b   Klitz, William ^c   Erlich, Henry A ^a   Visvikis, Sophia ^b   Chen, John J ^c   Pullinger, Clive R ^d   Malloy, Mary J ^e   Siest, Gérard ^b   Kane, John P ^e  

^a ROCHE MOLECULAR SYSTEMS   (United States)

^b Centre de Medecine Preventive   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

AMINO ACID METABOLISM; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; DNA DETERMINATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LIPID METABOLISM; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; THROMBOSIS;

EID: 0032696776     PISSN: 10889051     EISSN: None     Source Type: Journal    
DOI: 10.1101/gr.9.10.936     Document Type: Article

References (109)

1. Agellon, L.B., E.M. Quinet, T.G. Gillette, D.T. Drayna, M.L. Brown, and A.R. Tall. 1990. Organization of the human cholesteryl ester transfer protein gene. Biochemistry 29: 1372-1376.
2. Bell, G.I., J.H. Karam, and W.J. Rutter. 1981. Polymorphic DNA region adjacent to the 5′ end of the human insulin gene. Proc. Natl. Acad. Sci. 78: 5759-5763.
3. Bertina, R.M., B.P.C. Koeleman, T. Koster, F.R. Rosendaal, R.J. Dirven, H. de Ronde, P.A. van der Velden, and P.H. Reitsma. 1994. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64-67.
4. Bonnardeaux, A., E. Davies, X. Jeunemaitre, I. Féry, A. Charru, E. Clauser, L. Tiret, R. Cambien, P. Corvol, and F. Soubrier. 1994. Angiotensin II type I receptor gene polymorphisms in human essential hypertension. Hypertension 24: 63-69.
5. Bonne, G., L. Carrier, P. Richard, B. Hainque, and K. Schwartz. 1998. Familial hypertrophic cardiomyopathy: From mutations to functional defects. Circ. Res. 83: 580-593.
6. Cambien, F., O. Poirier, L. Lecerf, A. Evans, J.-P. Cambou, D. Arveiler, G. Luc, J.-M. Bard, L. Bara, S. Ricard, et al. 1992. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641-644.
7. 506). Arterioscler. Thromb. Vasc. Biol. 17: 1662-1666.
8. Cheng, S., C. Pallaud, M.A. Grow, S.J. Scharf, H.A. Erlich, W. Klitz, C.R. Pullinger, M.J. Malloy, J.P. Kane, G. Siest, and S. Visvikis. 1998. A multilocus genotyping assay for cardiovascular disease. Clin. Chem. Lab. Med. 36: 561-566.
9. Christensen, B., P. Frosst, S. Lussier-Cacan, J. Selhub, P. Goyette, D.S. Rosenblatt, J. Genest Jr., and R. Rozen. 1997. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 17: 569-573.
10. Clark, A.G., K.M. Weiss, D.A. Nickerson, S.L. Taylor, A. Buchanan, J. Stengård, V. Salomaa, E. Vartiainen, M. Perola, E. Boerwinkle, and C.F. Sing. 1998. Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am. J. Hum. Genet. 63: 595-612.
11. Cook, N.S. and D. Ubben. 1990. Fibrinogen as a major risk factor in cardiovascular disease. Trends Pharmacol. Sci. 11: 444-451.
12. Dammerman, M., L.A. Sandkuijl, J.L. Halaas, W. Chung, and J.L. Breslow. 1993. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc. Natl. Acad. Sci. 90: 4562-4566.
13. Dawber, T.R., G.F. Meadors, and F.F. Moore. 1951. Epidemiological approaches to heart disease: The Framingham study. Am. J. Public Health 41: 279-286.
14. Day, I.N.M., R.A. Whittall, S.D. O'Dell, L. Haddad, M.K. Bolla, V. Gudnason, and S.E. Humphries. 1997. Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia. Hum. Mutat. 10: 116-127.
15. de Knijff, P., A.M.J.M. van den Maagdenberg, R.R. Frants, and L.M. Havekes. 1994. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum. Mutat. 4: 178-194.
16. Dupont, B. 1987. Immunobiology of HLA, Vol. 1: Histocompatibility testing. Springer-Verlag, New York, NY.
17. Ehrenborg, E., S.M. Clee, S.N. Pimstone, P.W.A. Reymer, P. Benlian, C.F. Hoogendijk, H.J. Davis, N. Bissada, L. Miao, S.E. Gagné et al. 1997. Ethnic variation and in vivo effects of the -93t → g promoter variant in the lipoprotein lipase gene. Arterioscler. Thromb. Vasc. Biol. 17: 2672-2678.
18. Evans, A.E., O. Poirier, F. Kee, E. Lecerf, E. McCrum, T. Falconer, J. Crane, D.F. O'Rourke, and F. Cambien. 1994. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q. J. Med. 87: 211-214.
19. Frosst, P., H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, R.G. Matthews, G.J.H. Boers, M. den Heijer, L.A.J. Kluijtmans, L.P. van den Heuvel, and R. Rozen. 1995. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10: 111-113.
20. Funke, H., H. Wiebusch, L. Fuer, S. Muntoni, H. Schulte, and G. Assmann. 1994. Identification of mutations in the cholesterol ester transfer protein in Europeans with elevated high-density-lipoprotein cholesterol. Circulation 90: 241.
21. Gensini, G.G. 1975. Coronary arteriography. Futura Publishing Co., New York, NY.
22. Goyette, P., P. Frosst, D.S. Rosenblatt, and R. Rozen. 1995. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am. J. Hum. Genet. 56: 1052-1059.
23. Green, F., A. Hamsten, M. Blombäck, and S. Humphries. 1993. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb. Haemost. 70: 915-920.
24. Groenemeijer, B.E., M.D. Hallman, P.W.A. Reymer, E. Gagné, J.A. Kuivenhoven, T. Bruin, H. Jansen, K.I. Lie, A.V.G. Bruschke, E. Boerwinkle, M.R. Hayden, and J.J.P. Kastelein. 1997. Genetic variant showing a positive interaction with β-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. Circulation 95: 2628-2635.
25. Gudnason, V., K. Thormar, and S.E. Humphries. 1997. Interaction of the cholesteryl ester transfer protein I405V polymorphism with alcohol consumption in smoking and non-smoking healthy men, and the effect on plasma HDL cholesterol and apoAI concentration. Clin. Genet. 51: 15-21.
26. Haldane, J.B.S. 1955. The estimation and significance of the logarithm of a ratio of frequencies. Ann. Human Genet. 20: 309-311.
27. Hall, S., G. Chu, G. Miller, K. Cruickshank, J.A. Cooper, S.E. Humphries, and P.J. Talmud. 1997. A common mutation in the lipoprotein lipase gene promoter, - 93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro. Arterioscler. Thromb. Vasc. Biol. 17: 1969-1976.
28. Hata, A., M. Robertson, M. Emi, and J.-M. Lalouel. 1990. Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: Identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res. 18: 5407-5411.
29. Hegele, R.A., J.H. Brunt, and P.W. Connelly. 1995. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate. Arterioscler. Thromb. Vasc. Biol. 15: 89-95.
30. Hixson, J.E. and Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. 1991. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler. Thromb. Vasc. Biol. 11: 1237-1244.
31. Hixson, J.E. and D.T. Vernier. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31: 545-548.
32. Hobbs, H.H., M.S. Brown, and J.L. Goldstein. 1992. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mutat. 1: 445-466.
33. Hoeg, J.M. 1997. Evaluating coronary heart disease risk. J. Am. Med. Assoc. 277: 1387-1390.
34. Houlston, R.S., C. Snowden, F. Green, K.G.M.M. Alberti, and S.E. Humphries. 1989. Apolipoprotein (apo) E genotypes by polymerase chain reaction and allele-specific oligonucleotide probes: No detectable linkage disequilibrium between apo E and apo CII. Hum. Genet. 83: 364-368.
35. Hu, F.L., Z. Gu, V. Kozich, J.P. Kraus, V. Ramesh, and V.E. Shih. 1993. Molecular basis of cystathionine β-synthase gene deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum. Mol. Genet. 2: 1857-1860.
36. Humbert, R., D.A. Adler, C.M. Disteche, C. Hassett, C.J. Omiecinski, and C.E. Furlong. 1993. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3: 73-76.
37. Humphries, S.E. and P.J. Talmud. 1995. Hyperlipidaemia associated with genetic variation in the apolipoprotein B gene. Curr. Opin. Lipidol. 6: 215-222.
38. -455-A β-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Arterioscler. Thromb. Vasc. Biol. 15: 96-104.
39. Humphries, S.E., P.J. Talmud, C. Cox, W. Sutherland, and J. Mann. 1996. Genetic factors affecting the consistency and magnitude of changes in plasma cholesterol in response to dietary challenge. Quart. J. Med. 89: 671-680.
40. Humphries, S.E., A. Panahloo, H.E. Montgomery, F. Green, and J. Yudkin. 1997. Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis. Thromb. Haemost, 78: 457-461.
41. Jeunemaitre, X., F. Soubrier, Y.V. Kotelevtsev, R.P. Lifton, C.S. Williams, A. Charru, S.C. Hunt, P.N. Hopkins, R.R. Williams, J.-M. Lalouel, and P. Corvol. 1992. Molecular basis of human hypertension: Role of angiotensinogen. Cell 71: 169-180.
42. Jin, Y., H.C. Dietz, A. Nurden, and P.F. Bray. 1993. Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood 82: 2281-2288.
43. 9asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation 94: 1913-1918.
44. Leiden and thrombophilia. Arterioscler. Thromb. Vasc. Biol. 17: 620-627.
45. Klitz, W., J.C. Stephens, M. Grote, and M. Carrington. 1995. Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. Am. J. Hum. Genet. 57: 1436-1444.
46. Kluijtmans, L.A.J., L.P.W.J. van den Heuvel, G.H.J. Boers, P. Frosst, E.M.B. Stevens, B.A. van Oost, M. den Heijer, F.J.M. Trijbels, R. Rozen, and H.J. Blom. 1996. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am. J. Hum. Genet. 58: 35-41.
47. Kozich, V. and J.P. Kraus. 1992. Screening for mutations by expressing patient cDNA segments in E. coli: Homocystinuria due to cystathionine β-synthase deficiency. Hum. Mutat. 1: 113-123.
48. Kozich, V., R. de Franchis, and J.P. Kraus. 1993. Molecular defect in a patient with pyridoxine-responsive homocystinuria. Hum. Mol. Genet. 2: 815-816.
49. 447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males. Arterioscler. Thromb. Vasc. Biol. 17: 595-599.
50. Kuivenhoven, J.A., J.W. Jukema, A.H. Zwinderman, P. de Knijff, R. McPherson, A.V.G. Bruschke, K.I. Lie, and J.J.P. Kastelein. 1998. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N. Engl. J. Med. 338: 86-93.
51. Lassel, T.S., M. Guérin, S. Auboiron, M.J. Chapman, and B. Guy-Grand. 1998. Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 18: 65-74.
52. Lewontin, R.C. 1964. The interaction of selection and linkage. I. General considerations: Heterotic models. Genetics 49: 49-67.
53. Lindpaintner, K., M.A. Pfeffer, R. Kreutz, M.J. Stampfer, F. Grodstein, F. LaMotte, J. Buring, and C.H. Hennekens. 1995. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. 332: 706-711.
54. Longo, M.C., M.S. Berninger, and J.L. Hartley. 1990. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 93: 125-128.
55. Ludwig, E., P.S. Corneli, J.L. Anderson, H.W. Marshall, J.-M. Lalouel, and R.H. Ward. 1995. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 91: 2120-2124.
56. Mackness, M.I., S. Arrol, B. Mackness, and P.N. Durrington. 1997. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation. Lancet 349: 851-852.
57. Mahley, R.W. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240: 622-630.
58. Mailly, F., Y. Tugrul, P.W.A. Reymer, T. Bruin, M. Seed, B.F. Groenemeyer, A. Asplund-Carlson, D. Vallance, A.F. Winder, G.J. Miller et al. 1995. A common variant in the gene for lipoprotein lipase (Asp9 → Asn). Arterioscler. Thromb. Vasc. Biol. 15: 468-478.
59. Mannucci, P.M. 1995. Recent progress in the pathophysiology of fibrinogen. Eur. Heart J. (Suppl.A)16: 25-30.
60. 6 nonresponsive homocystinuria. Hum. Mol. Genet. 3: 1883-1886.
61. Miller, S.A., D.D. Dykes, and H.F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
62. Morgan, L., F.B. Pipkin, and N. Kalsheker. 1996. Angiotensinogen: Molecular biology, biochemistry and physiology. Int. J. Biochem. Cell Biol. 28: 1211-1222.
63. Mullis, K.B. and F.A. Faloona. 1987. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods in Enzymol. 155: 335-350.
64. Neugebauer, M., J. Willems, and M.P. Baur. 1984. Analysis of multilocus pedigree data by computer. In Histocompatibility testing (ed. E.D. Albert), pp. 52-58. Springer-Verlag, Berlin, Germany.
65. 33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J. Clin. Invest. 83: 1778-1781.
66. Nickerson, D.A., S.L. Taylor, K.M. Weiss, A.G. Clark, R.G. Hutchinson, J. Stengård, V. Salomaa, E. Vartiainen, E. Boerwinkle, and C.F. Sing. 1998. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat. Genet. 19: 233-240.
67. Nurden, A.T. 1996. Polymorphisms of human platelet membrane glycoproteins: Structure and clinical significance. Thromb. Haemost. 74: 345-351.
68. Oka, K., G.T. Tkalcevic, T. Nakano, H. Tucker, K. Ishimura-Oka, and W.V. Brown. 1990. Structure and polymorphic map of human lipoprotein lipase gene. Biochim. Biophys. Acta 1049: 21-26.
69. Ordovas, J.M., F. Civeira, J. Genest Jr., S. Craig, A.H. Robbins, T. Meade, M. Pocovi, P.M. Frossard, U. Masharani, P.W.F. Wilson et al. 1991. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Atherosclerosis 87: 75-86.
70. Pasternak, R.C., S.M. Grundy, D. Levy, and P.D. Thompson. 1996. 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 3. Spectrum of risk factors for coronary heart disease. J. Am. Coll. Cardiol. 27: 978-990.
71. Pastinen, T., M. Perola, P. Niini, J. Terwilliger, V. Salomaa, E. Vartiainen, L. Peltonen, and A.-C. Syvänen. 1998. Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population. Hum. Mol. Genet. 7: 1453-1462.
72. Pullinger, C.R., L.K. Hennessy, J.E. Chatterton, W. Liu, J.A. Love, C.M. Mendel, P.H. Frost, M.J. Malloy, V.N. Schumaker, and J.P. Kane. 1995. Familial ligand-defective apolipoprotein B. J. Clin. Invest. 95: 1225-1234.
73. Rees, A., J. Stocks, C.R. Sharpe, M.A. Vella, C.C. Shoulders, J. Katz, N.I. Jowett, F.E. Baralle, and D.J. Galton. 1985. Deoxyribonucleic acid polymorphism in the apolipoprotein A-I-C-III gene cluster. J. Clin. Invest. 76: 1090-1095.
74. Reymer, P.W.A., B.E. Groenemeyer, E. Gagné, L. Miao, E.E.G. Appelman, J.C. Seidell, D. Kromhout, S.M. Bijvoet, K. van de Oever, T. Bruin, M.R. Hayden, and J.J.P. Kastelein. 1995. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum. Mol. Genet. 4: 1543-1549.
75. Ridker, P.M., C.H. Hennekens, K. Lindpaintner, M.J. Stampfer, P.R. Eisenberg, and J.P. Miletich. 1995. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N. Engl. J. Med. 332: 912-917.
76. A1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 349: 385-388.
77. Rigat, B., C. Hubert, P. Corvol, and F. Soubrier. 1992. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 20: 1433.
78. Saiki, R.K., D.H. Gelfand, S. Stoffel, S.J. Scharf, R. Higuchi, G.T. Horn, K.B. Mullis, and H.A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487-491.
79. Saiki, R.K., P.S. Walsh, C.H. Levenson, and H.A. Erlich. 1989. Genetic analysis of amplified DNA with immobilized sequence-specific oligonudeotide probes. Prof. Natl. Acad. Sci. 86: 6230-6234.
80. Salah, D., K. Bohnet, R. Gueguen, G. Siest, and S. Visvikis. 1997. Combined effects of lipoprotein lipase and apolipoprotein levels in the Stanislas Cohort. J. Lipid Res. 38: 132-141.
81. Sanghera, D.K., N. Saha, C.E. Aston, and M.I. Kamboh. 1997. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 17: 1067-1073.
82. Sebastio, G., M.P. Sperandeo, M. Panico, R. de Franchis, J.P. Kraus, and G. Andria. 1995. The molecular basis of homocystinuria due to cystathionine β-synthase deficiency in Italian families, and report of four novel mutations. Am. J. Hum. Genet. 56: 1324-1333.
83. Serrato, M. and A.J. Marian. 1995. A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J. Clin. Invest. 96: 3005-3008.
84. Siest, G., S. Visvikis, B. Herbeth, R. Gueguen, M. Vincent-Viry, C. Sass, B. Beaud, E. Lecomte, J. Steinmetz, J. Locuty, and P. Chevrier. 1998. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: The Stanislas Cohort. Clin. Chem. Lab. Med. 36: 35-42.
85. Sokal, R.R. and F.J. Rohlf. 1995. Biometry, 3rd ed. W.H. Freeman, San Francisco, CA.
86. Soria, L.F., E.H. Ludwig, H.R.G. Clarke, G.L. Vega, S.M. Grundy, and B.J. McCarthy. 1989. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Prof. Natl. Acad. Sci. 86: 587-591.
87. Sperandeo, M.P., R. de Franchis, G. Andria, and G. Sebastio. 1996. A 68-bp insertion found in a homocystinuric patient is a common variant and is skipped by alternative splicing of the cystathionine β-synthase mRNA. Am. J. Hum. Genet. 59: 1391-1393.
88. Takahashi, K., X.-C. Jiang, N. Sakai, S. Yamashita, K. Hirano, H. Bujo, H. Yamazaki, J. Kusunoki, T. Miura, P. Kussie, et al. 1993. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J. Clin. Invest. 92: 2060-2064.
89. Tall, A. 1995. Plasma lipid transfer proteins. Annu. Rev. Biochem. 64: 235-257.
90. The MRFIT Research Group. 1982. Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. J. Am. Med. Assoc. 248: 1465-1477.
91. The Women's Health Initiative Study Group. 1998. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control. Clin. Trials 19: 61-109.
92. Thein, S.L. and R.B. Wallace. 1986. The use of synthetic oligonucleotides as specific hybridization probes in the diagnosis of genetic disorders (ed. K.E. Davies), pp. 33-50. IRL Press, Oxford, UK.
93. Tikkanen, M.J., J. Viikari, H.K. Åkerblom, and E. Pesonen. 1988. Apolipoprotein B polymorphism and altered apolipoprotein B and low density lipoprotein cholesterol concentrations in Finnish children. Br. Med. J. 296: 169-170.
94. Tiret, L., A, Bonnardeaux, O. Poirier, S. Ricard, P. Marques-Vidal, A. Evans, D. Arveiler, G. Luc, F. Kee, P. Ducimetie↓re, F. Soubrier, and F. Cambien. 1994. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type I receptor gene polymorphisms on risk of myocardial infarction. Lancet 344: 910-913.
95. Tsai, M.Y., M. Bignell, K. Schwichtenberg, and N.Q. Hanson. 1996. High prevalence of a mutation in the cystathionine β-synthasegene. Am. J. Hum. Genet. 59: 1262-1267.
96. Tung, C.H., M.J. Rudolph, and S. Stein. 1991. Preparation of oligonucleotide-peptide conjugates. Bioconjugate Chem. 2: 464-465.
97. University College of London, accessed 1999. LDL-receptor mutation catalogue. http://www.ucl.ac.uk/fh.
98. Weiss, E.J., P.F. Bray, M. Tayback, S.P. Schulman, T.S. Kickler, L.C. Becker, J.L. Weiss, G. Gerstenblith, and P.J. Goldschmidt-Clermont. 1996. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N. Engl. J. Med. 334: 1090-1094.
99. Wenzel, K., M. Ernst, K. Rohde, G. Baumann, and A. Speer. 1996. DNA polymorphisms in adhesion molecule genes - A new risk factor for early atherosclerosis. Hum. Genet. 97: 15-20.
100. Wenzel, K., S. Felix, F.X. Kleber, R. Brachold, T. Menke, S. Schattke, K.L. Schulte, C. Gläser, K. Rohde, G. Baumann, and A. Speer. 1994. E-selectin polymorphism and atherosclerosis: An association study. Hum. Mol. Genet. 3: 1935-1937.
101. Wetmur, J.G. 1991. DNA probes: Applications of the principles of nucleic acid hybridization. Crit. Rev. Biochem. Mol. Biol. 26: 227-259.
102. Wilson, P.W.F., R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel. 1998. Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837-1847.
103. Xu, C.-F., P. Talmud, H. Schuster, R. Houlston, G. Miller, and S. Humphries. 1994. Association between genetic variation at the Apo AI-CIII-AIV gene cluster and familial combined hyperlipidaemia. Clin. Genet. 46: 385-397.
104. Yang, W.-S., D.N. Nevin, R. Peng, J.D. Brunzell, and S.S. Deeb. 1995a. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc. Natl. Acad. Sci. 92: 4462-4466.
105. _. 1995b. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc. Natl. Acad. Sci. 93: 524.
106. 2 in subjects with coronary artery disease and hypercholesterolemia. Arteriosclerosis 7: 61-65.
107. Young, S.G. and S.T. Hubl. 1989. An ApaLI restriction site polymorphism is associated with the MB19 polymorphism in apolipoprotein B. J. Lipid Res. 30: 443-449.
108. Zhang, H., P.W.A. Reymer, M.-S. Liu, I.J. Forsythe, B.E. Groenemeyer, J. Frohlich, J.D. Brunzell, J.J.P. Kastelein, M.R. Hayden, and Y. Ma. 1995. Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an asn 291 → ser mutation in the human LPL gene. Arterioscler. Thromb. Vasc. Biol. 15: 1695-1703.
109. Zhong, S., D.S. Sharp, J.S. Grove, C. Bruce, K. Yano, J.D. Curb, and A.R. Tall. 1996. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest. 97: 2917-2923.